QQQ $ 454.82 $ 1.86 (0.41 %)
DIA $ 398.57 $ 0.68 (0.17 %)
SPY $ 530.36 $ 1.87 (0.35 %)
TLT $ 91.26 $ 0.49 (0.54 %)
GLD $ 225.37 $ -0.34 (-0.15 %)
$ 11.7
-- x --
-- x --
-- - --
$ 3.42 - $ 14.50
494,606
na
2.22B
$ 1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

DOJ proposes reclassifying cannabis to Schedule III. WTR's report highlights market gains and potential industry impacts. R...

 cannabis-stocks-under-2-why-are-these-small-cap-shares-up-while-broader-sector-is-in-the-red

Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These sto...

 ron-desantis-will-accept-will-of-the-people-if-we-choose-cannabis-legalization-in-floridas-nov-ballot-says-trulieve-ceo-kim-rivers

Kim Rivers has attended nearly every Benzinga Cannabis Capital Conference and will likely join us again in Chicago this Oct. 8-9.

 rescheduling-marijuana-how-dojs-action-could-transform-the-industry

By Todd Harrison via Cannabis Confidential (May 17)

 cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled ...

 weed-industry-celebrates-bidens-rescheduling-move-most-monumental-cannabis-reform-in-half-a-century

Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a m...

 florida-cannabis-legalization-amendment-ads-hit-airwaves-the-first-4-pitches-for-legal-weed-in-the-sunshine-state

The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more...

 analysts-may-need-to-revise-cannabis-stock-projections-for-2024-10-companies-surpass-ebitda-estimates-by-37m

Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state op...

 heres-where-to-buy-legal-weed-floridas-thriving-cannabis-landscape-and-more-new-marijuana-stores-in-us-and-canada

In anticipation of the outcome of Florida's Measure 3, cannabis giants are racing to bolster their retail footprint statewi...

 cannabis-reports-highlight-339m-and-2976m-revenue-insights-in-curaleaf-and-trulieves-q1-2024-financials

A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legisla...

 roth-mkm-maintains-buy-on-trulieve-cannabis-raises-price-target-to-19

Roth MKM analyst Scott Fortune maintains Trulieve Cannabis (OTC:TCNNF) with a Buy and raises the price target from $16 to $19.

 needham-maintains-buy-on-trulieve-cannabis-raises-price-target-to-145

Needham analyst Matt McGinley maintains Trulieve Cannabis (OTC:TCNNF) with a Buy and raises the price target from $13.5 to $...

 medical-marijuana-giant-trulieve-backer-of-floridas-recreational-cannabis-ballot-narrows-loss-reports-uptick-in-q1-revenue-gross-profit

Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahas...

 big-players-in-us-cannabis-could-play-the-stock-value-card-in-ma-new-report-shows

As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to 

 cannabis-stocks-retreat-on-new-rescheduling-order-developments-whats-going-on

The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits ...

 credit-check-what-does-dea-rescheduling-mean-for-cannabis-credit-ratings-big-companies-risk-return-profiles

The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION